108 results
Page 3 of 6
8-K
EX-99.1
l1obb5r e5xl70v2gkt
28 Feb 22
Arvinas Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
4:56pm
8-K
5la2igm
17 Feb 22
Regulation FD Disclosure
8:01am
8-K
EX-99.1
dceqpo2 x9
17 Feb 22
Regulation FD Disclosure
8:01am
8-K
EX-99.2
gcsb0qnhui8dpqv12f
17 Feb 22
Regulation FD Disclosure
8:01am
8-K
EX-99.1
80w257q8
10 Dec 21
Regulation FD Disclosure
8:16am
8-K
EX-99.1
2fulj
3 Nov 21
Arvinas Reports Third Quarter 2021 Financial Results and Provides Corporate Update
4:01pm
424B5
hczmw6hry4fx68l97
6 Aug 21
Prospectus supplement for primary offering
4:34pm
8-K
EX-1.1
7esho3wd08vhi e3p9
6 Aug 21
Entry into a Material Definitive Agreement
4:09pm
8-K
EX-99.1
tfgao082
5 Aug 21
Arvinas Reports Second Quarter 2021 Financial Results and Provides Corporate Update
4:02pm
8-K
EX-10.1
cp1 agvwqp2e
22 Jul 21
Arvinas and Pfizer Announce Global Collaboration to Develop and Commercialize PROTAC® Protein
7:30am
8-K
EX-10.2
2ilrnb7n9dq
22 Jul 21
Arvinas and Pfizer Announce Global Collaboration to Develop and Commercialize PROTAC® Protein
7:30am
8-K
EX-99.1
phy6u abti0f
22 Jul 21
Arvinas and Pfizer Announce Global Collaboration to Develop and Commercialize PROTAC® Protein
7:30am
8-K
EX-10.3
wwoz0l77f9
22 Jul 21
Arvinas and Pfizer Announce Global Collaboration to Develop and Commercialize PROTAC® Protein
7:30am
8-K
xq75wc 01a28
22 Jul 21
Arvinas and Pfizer Announce Global Collaboration to Develop and Commercialize PROTAC® Protein
7:30am